Annual CFI
$0.00
-$1.16 M-100.00%
31 December 2023
Summary:
Hoth Therapeutics annual cash flow from investing activities is currently $0.00, with the most recent change of -$1.16 million (-100.00%) on 31 December 2023. During the last 3 years, it has risen by +$1.84 million (+100.00%). HOTH annual CFI is now -100.00% below its all-time high of $1.16 million, reached on 31 December 2022.HOTH Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
30 September 2024
Summary:
Hoth Therapeutics quarterly cash flow from investing activities is not available.HOTH Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
30 September 2024
Summary:
Hoth Therapeutics TTM cash flow from investing activities is not available.HOTH TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HOTH Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -100.0% | - | - |
3 y3 years | +100.0% | - | - |
5 y5 years | 0.0% | - | - |
HOTH Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -100.0% | +100.0% | ||||
5 y | 5 years | -100.0% | +100.0% | ||||
alltime | all time | -100.0% | +100.0% |
Hoth Therapeutics Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $0.00(-100.0%) | - | - |
Dec 2022 | $1.16 M(-802.4%) | -$7500.00(-175.0%) | $1.16 M(+0.9%) |
Sept 2022 | - | $10.00 K(-99.2%) | $1.15 M(+104.7%) |
June 2022 | - | $1.18 M(-4836.8%) | $562.60 K(-149.0%) |
Mar 2022 | - | -$25.00 K(+42.9%) | -$1.15 M(+593.8%) |
Dec 2021 | -$165.40 K(-91.0%) | -$17.50 K(-97.0%) | -$165.40 K(-82.9%) |
Sept 2021 | - | -$579.10 K(+10.1%) | -$969.70 K(-445.1%) |
June 2021 | - | -$526.00 K(-155.0%) | $281.00 K(-131.5%) |
Mar 2021 | - | $957.20 K(-216.5%) | -$890.70 K(-51.5%) |
Dec 2020 | -$1.84 M | -$821.80 K(-222.4%) | -$1.84 M(+76.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2020 | - | $671.60 K(-139.6%) | -$1.04 M(-59.4%) |
June 2020 | - | -$1.70 M(<-9900.0%) | -$2.56 M(+192.9%) |
Mar 2020 | - | $10.20 K(-140.8%) | -$874.80 K(-2.3%) |
Dec 2019 | -$895.00 K(<-9900.0%) | -$25.00 K(-97.1%) | -$895.00 K(+2.9%) |
Sept 2019 | - | -$850.00 K(+8400.0%) | -$870.00 K(+4250.0%) |
June 2019 | - | -$10.00 K(0.0%) | -$20.00 K(+100.0%) |
Mar 2019 | - | -$10.00 K(<-9900.0%) | -$10.00 K(<-9900.0%) |
Dec 2018 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
June 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2018 | - | $0.00 | $0.00 |
FAQ
- What is Hoth Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Hoth Therapeutics?
- What is Hoth Therapeutics annual CFI year-on-year change?
- What is the all time high quarterly CFI for Hoth Therapeutics?
- What is the all time high TTM CFI for Hoth Therapeutics?
What is Hoth Therapeutics annual cash flow from investing activities?
The current annual CFI of HOTH is $0.00
What is the all time high annual CFI for Hoth Therapeutics?
Hoth Therapeutics all-time high annual cash flow from investing activities is $1.16 M
What is Hoth Therapeutics annual CFI year-on-year change?
Over the past year, HOTH annual cash flow from investing activities has changed by -$1.16 M (-100.00%)
What is the all time high quarterly CFI for Hoth Therapeutics?
Hoth Therapeutics all-time high quarterly cash flow from investing activities is $1.18 M
What is the all time high TTM CFI for Hoth Therapeutics?
Hoth Therapeutics all-time high TTM cash flow from investing activities is $1.16 M